v3.26.3
STOCKHOLDERS’ EQUITY (Tables)
 9 Months Ended
Jul. 31, 2026
Equity [Abstract]  
SCHEDULE OF OPTION ACTIVITY

The table below presents option activity for the nine months ended July 31, 2026 and the year ended October 31, 2025:

 

  

Number of

Shares

  

Weighted Average

Exercise Price

per Share

  

Weighted Average

Remaining Contractual

Life (in years)

  

Aggregate

intrinsic value

 
Balance at October 31, 2024   1,112,923   $10.84    5.64   $1,560,431 
Options exercised   -    -    -    - 
Options granted   -    -    -    - 
Options expired   -    -    -    - 
Options forfeited   -    -    -    - 
Balance at October 31, 2025   1,112,923    10.84    4.64    501,923 
Options exercised   (84,615)   1.30    -    - 
Options granted   -    -    -    - 
Options expired   -    -    -    - 
Options forfeited   -    -    -    - 
Balance at July 31, 2026   1,028,308   $11.62    4.07   $375,000 
SCHEDULE OF COMMON STOCK UNDERLYING OUTSTANDING WARRANTS

A summary of the Company’s common stock underlying its outstanding A and B warrants as of July 31, 2026 and October 31, 2025 is as follows:

 

  

Underlying

Number of Shares

  

Average

Exercise Price

  

Weighted

Average Life

 
Outstanding – October 31, 2024   261,650   $26.00    1.31 
Warrants A – Granted during the period   -    -    - 
Warrants B – Granted during the period   -    -    - 
Warrants A – Expired during the period   (78,846)   26.00    - 
Warrants B – Expired during the period   -    -    - 
Outstanding – October 31, 2025   182,804    26.00    0.70 
Warrants A – Granted during the period   -    -    - 
Warrants B – Granted during the period   -     -    - 
Warrants A – Expired during the period   -    -    - 
Warrants B – Expired during the period   (113,846)   -    - 
Outstanding – July 31, 2026   68,958   $26.00    0.11 
 

A summary of the Company’s common stock underlying its outstanding pre-funded warrants as of July 31, 2026 and October 31, 2025 is as follows:

 

  

Underlying

Number of Shares

  

Average

Exercise Price

  

Weighted

Average Life

 
Outstanding – October 31, 2024   1,107,500   $0.001    N/A 
Pre-Funded Warrants – Granted during the period   276,000    0.001    N/A 
Pre-Funded Warrants – Exercised during the period   -    -    - 
Pre-Funded Warrants – Expired during the period   -    -    - 
Outstanding – October 31, 2025   1,383,500    0.001    N/A 
Pre-Funded Warrants – Granted during the period   -    -    - 
Pre-Funded Warrants – Exercised during the period   -    -    - 
Pre-Funded Warrants – Expired during the period   -    -    - 
Outstanding – July 31, 2026   1,383,500   $0.001    N/A 
  

A summary of the Company’s common stock underlying other warrants as of July 31, 2026 and October 31, 2025 is as follows:

 

  

Underlying

Number of Shares

  

Average

Exercise Price

  

Weighted

Average Life

 
Outstanding – October 31, 2024   -   $-    N/A 
Warrants – Issued during the period   -    -    N/A 
Warrants – Exercised during the period   -    -    - 
Warrants – Expired during the period   -    -    - 
Outstanding – October 31, 2025   -    -    N/A 
Warrants – Issued during the period   2,269,763    4.57    N/A 
Warrants – Exercised during the period   -    -    - 
Warrants – Expired during the period   -    -    - 
Outstanding – July 31, 2026   2,269,763   $4.57    N/A